You can read the IBTA e-News March 2017 edition in full online here.
Some of the highlights from this month's include:
- The IBTA’s free Brain Tumour magazine World Edition 2017/18 is soon due to be released. This year 14,000 copies will be printed and sent for free to recipients in 111 countries and widely distributed at international neuro-oncology and cancer conferences. If you would like to receive a copy of Brain Tumour magazine please register on the IBTA website using this form. To read previous years’ editions online click here.
- A published clinical trial has confirmed that adding chemotherapy to radiotherapy treatment improves the survival of elderly patients with newly diagnosed glioblastoma.
- A study that has analysed the medical records of 78 children with ependymoma over a 13 year period has concluded that proton-beam therapy gives 'comparable’ results to intensity-modulated radiation therapy, and that the success of surgery is the key factor affecting survival.
- Writing in The Lancet Oncology, an international team of researchers has devised a new classification for meningiomas, based on their genetic features rather than their (histological) appearance under microscope, as is still the case with current WHO categorisation.
- The Children’s Brain Tumour Drug Delivery Consortium has been launched and is an international collaboration that aims to explore novel drug delivery systems that can physically bypass the blood brain barrier.
- A study published in Clinical Cancer Research has cast doubt on a theory that cytomegalovirus (CMV) - a common virus that infects people of all ages, usually with few symptoms - could have a role in glioblastoma.
- May will be Brain Tumor Awareness Month in the USA and Canada, during which time fundraising, awareness-raising and advocacy events will be taking place across North America. This will be the second Brain Tumour Awareness Month in Canada taking place in May, and coincides with the Brain Tumour Foundation of Canada celebrating its 35th anniversary. Now in its sixth year, ependymoma Awareness Day will be held on May 8, 2017. In Australia, Brain Tumour Alliance Australia will be running events throughout ‘Brain Cancer Action Month’.
- A new report has been published by the All.Can group that looks at the need to improve efficiency in cancer care by focusing on patient outcomes. See our article on the report here.
Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to nearly 7,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences. You can sign up to receive the e-News every month by registering here.
To see an archive of existing e-News issues, click here.